Search

Your search keyword '"Thomas H. King"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Thomas H. King" Remove constraint Author: "Thomas H. King"
41 results on '"Thomas H. King"'

Search Results

1. Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs

2. Bridging Animal and Human Data in Pursuit of Vaccine Licensure

3. Data from Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model

4. Supplementary Table 1 from Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model

5. Data from Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process

9. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.

10. Undermining during cutaneous wound closure for wounds less than 3 cm in diameter: a randomized split wound comparative effectiveness trial

11. Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants

12. Dermal suture only versus layered closure: A randomized, split wound comparative effectiveness trial

13. Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection

14. Does wound eversion improve cosmetic outcome?

15. GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis

16. Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process

17. Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model

18. Perceptions of Aesthetic Outcome of Linear vs Multiple Z-Plasty Scars in a National Survey

19. Construction and Immunogenicity Testing of Whole Recombinant Yeast-Based T-Cell Vaccines

20. Construction and Immunogenicity Testing of Whole Recombinant Yeast-Based T-Cell Vaccines

21. Strong dependence between functional domains in a dual-function snoRNA infers coupling of rRNA processing and modification events

22. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins

23. Effect of Adhesive Strips and Dermal Sutures vs Dermal Sutures Only on Wound Closure: A Randomized Clinical Trial

24. Purse-string suture vs second intention healing: results of a randomized, blind clinical trial

25. A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance

26. Electrobrasion vs. manual dermabrasion: a randomized, double-blind, comparative effectiveness trial

27. Set-back versus buried vertical mattress suturing: results of a randomized blinded trial

28. Point Mutations in Yeast CBF5 Can Abolish In Vivo Pseudouridylation of rRNA

29. To cut or not to cut? A review of aesthetic approaches to the facial subcutaneous cyst

30. Maintaining tissue orientation during mohs micrographic surgery: scalpel versus marker

31. Mutation Specific Control of BCR-ABL T315I Positive Leukemia with a Recombinant Yeast-Based Therapeutic Vaccine in a Murine Model

33. Yeasts encoding tumour antigens in cancer immunotherapy

34. Antisense and RNAi: powerful tools in drug target discovery and validation

35. Ribosome structure and activity are altered in cells lacking snoRNPs that form pseudouridines in the peptidyl transferase center

36. Abstract A28: Immune responses to mutated Ras - development of a yeast-based immunotherapeutic

37. A well-connected and conserved nucleoplasmic helicase is required for production of box C/D and H/ACA snoRNAs and localization of snoRNP proteins

38. A phase II study of a yeast-based therapeutic cancer vaccine, GI-6207, targeting CEA in patients with minimally symptomatic, metastatic medullary thyroid cancer

39. Abstract 752: The effect of food on the pharmacokinetics of tivozanib

41. Roadside Rock Art

Catalog

Books, media, physical & digital resources